Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiki Ueno

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Cancer Discovery|May 31, 2023
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney CancerBlake R Wilde, Nishma Chakraborty, Nedas Matulionis, et al.
Journal of Robotic Surgery|November 20, 2025
Outcomes of robot-assisted partial nephrectomy (RAPN) for cystic renal tumorKota Kobayashi, Hiroki Ito, Yasuhiro Numata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Genomic Heterogeneity and the Small Renal MassDaiki Ueno, Zuoquan Xie, Marta Boeke, et al.
BMC Cancer|January 11, 2017
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapyNoboru Nakaigawa, Keiichi Kondo, Daiki Ueno, et al.
Scientific Reports|July 2, 2025
Impact of the "L" score from the RENAL nephrometry score on RAPN surgical outcomes in medial versus lateral renal tumorsYasuhiro Numata, Hiroki Ito, Seiichiro Honda, et al.
European Urology|September 25, 2020
Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) ClassifierPatrick D McGillivray, Daiki Ueno, Aydin Pooli, et al.
BMC Cancer|February 10, 2016
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinomaNoboru Nakaigawa, Keiichi Kondo, Ukihide Tateishi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 20, 2025
Evaluation of Complication, Renal Function, and Recurrence-Free Survival in Hilar and Non-Hilar Tumors During Robot-Assisted Partial Nephrectomy: A Propensity Score-Matched AnalysisKentaro Muraoka, Daiki Takeya, Kazuhiro Nishimura, et al.
Molecular Pharmacology|June 9, 2019
Inhibition of Heat Shock Protein 90 suppresses TWIST1 TranscriptionKay Yi Chong, Min Kang, Francesca Garofalo, et al.
BMC Cancer|May 4, 2012
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease courseDaiki Ueno, Masahiro Yao, Ukihide Tateishi, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cancer Discovery|May 31, 2023
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney CancerBlake R Wilde, Nishma Chakraborty, Nedas Matulionis, et al.
Journal of Robotic Surgery|November 20, 2025
Outcomes of robot-assisted partial nephrectomy (RAPN) for cystic renal tumorKota Kobayashi, Hiroki Ito, Yasuhiro Numata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Genomic Heterogeneity and the Small Renal MassDaiki Ueno, Zuoquan Xie, Marta Boeke, et al.
BMC Cancer|January 11, 2017
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapyNoboru Nakaigawa, Keiichi Kondo, Daiki Ueno, et al.
Scientific Reports|July 2, 2025
Impact of the "L" score from the RENAL nephrometry score on RAPN surgical outcomes in medial versus lateral renal tumorsYasuhiro Numata, Hiroki Ito, Seiichiro Honda, et al.
European Urology|September 25, 2020
Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) ClassifierPatrick D McGillivray, Daiki Ueno, Aydin Pooli, et al.
BMC Cancer|February 10, 2016
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinomaNoboru Nakaigawa, Keiichi Kondo, Ukihide Tateishi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 20, 2025
Evaluation of Complication, Renal Function, and Recurrence-Free Survival in Hilar and Non-Hilar Tumors During Robot-Assisted Partial Nephrectomy: A Propensity Score-Matched AnalysisKentaro Muraoka, Daiki Takeya, Kazuhiro Nishimura, et al.
Molecular Pharmacology|June 9, 2019
Inhibition of Heat Shock Protein 90 suppresses TWIST1 TranscriptionKay Yi Chong, Min Kang, Francesca Garofalo, et al.
BMC Cancer|May 4, 2012
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease courseDaiki Ueno, Masahiro Yao, Ukihide Tateishi, et al.
Pageof 4